(2R,4S)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride

Catalog No. :
ACEMOI147
CAS No. :
2230826-34-1
Molecular Formula :
C22H31ClN4O3S
Molecular Weight :
467.04

IUPAC Name:(2R,4S)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride

(2R,4S)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,4S)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride
IUPAC Name(2R,4S)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride
Molecular FormulaC22H31ClN4O3S
Molecular Weight467.04
SMILESCC1=C(C2=CC=C(CNC(=O)[C@H]3C[C@H](O)CN3C(=O)[C@@H](N)C(C)(C)C)C=C2)SC=N1.Cl
InChI KeyJYRTWGCWUBURGU-DRSYXNBCSA-N
CAS No.2230826-34-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEMOI147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEOPF698 route compound structure diagram
    ACEOPF6982417159-60-3
  2. Then
  3. ACEMOI147 route product structure diagram
    ACEMOI1472230826-34-1
Inquiry

2. ACEMOI147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMOI147 route product structure diagram
    ACEMOI1472230826-34-1
Inquiry

Comments (0)